» Articles » PMID: 39043786

New Nano-complexes Targeting Protein 3S7S in Breast Cancer and Protein 4OO6 in Liver Cancer Investigated in Cell Line

Overview
Journal Sci Rep
Specialty Science
Date 2024 Jul 23
PMID 39043786
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer, a lethal ailment, possesses a multitude of therapeutic alternatives to combat its presence, metal complexes have emerged as significant classes of medicinal compounds, exhibiting considerable biological efficacy, especially as anticancer agents. The utilization of cis-platin in the treatment of various cancer types, including breast cancer, has served as inspiration to devise novel nanostructured metal complexes for breast cancer therapy. Notably, homo- and hetero-octahedral bimetallic complexes of an innovative multifunctional ether ligand (comprising Mn(II), Ni(II), Cu(II), Zn(II), Hg(II), and Ag(I) ions) have been synthesized. To ascertain their structural characteristics, elemental and spectral analyses, encompassing IR, UV-Vis, H-NMR, mass and electron spin resonance (ESR) spectra, magnetic moments, molar conductance, thermal analysis, and electron microscopy, were employed. The molar conductance of these complexes in DMF demonstrated a non-electrolytic nature. Nanostructured forms of the complexes were identified through electron microscopic data. At ambient temperature, the ESR spectra of the solid complexes exhibited anisotropic and isotropic variants, indicative of covalent bonding. The ligand and several of its metal complexes were subjected to cytotoxicity testing against breast cancer protein 3S7S and liver cancer protein 4OO6, with the Ag(I) complex (7) evincing the most potent effect, followed by the Cu(II) with ligand (complex (2)), Cis-platin, the ligand itself, and the Cu(II)/Zn(II) complex (8). Molecular docking data unveiled the inhibitory order of several complexes.

References
1.
Opletalova V, Kalinowski D, Vejsova M, Kunes J, Pour M, Jampilek J . Identification and characterization of thiosemicarbazones with antifungal and antitumor effects: cellular iron chelation mediating cytotoxic activity. Chem Res Toxicol. 2008; 21(9):1878-89. DOI: 10.1021/tx800182k. View

2.
Bernhardt P, Mattsson J, Richardson D . Complexes of cytotoxic chelators from the dipyridyl ketone isonicotinoyl hydrazone (HPKIH) analogues. Inorg Chem. 2006; 45(2):752-60. DOI: 10.1021/ic051573l. View

3.
Green D, Antholine W, Wong S, Richardson D, Chitambar C . Inhibition of malignant cell growth by 311, a novel iron chelator of the pyridoxal isonicotinoyl hydrazone class: effect on the R2 subunit of ribonucleotide reductase. Clin Cancer Res. 2001; 7(11):3574-9. View

4.
Qi G, Yang Z, Qin D . Synthesis, characterization and DNA-binding properties of the Cu(II) complex with 7-methoxychromone-3-carbaldehyde-benzoylhydrazone. Chem Pharm Bull (Tokyo). 2009; 57(1):69-73. DOI: 10.1248/cpb.57.69. View

5.
Bosch F, Rosich L . The contributions of Paul Ehrlich to pharmacology: a tribute on the occasion of the centenary of his Nobel Prize. Pharmacology. 2008; 82(3):171-9. PMC: 2790789. DOI: 10.1159/000149583. View